225 -270 million usd in revenue, page-2

i remember playing around with these 4 or 5 years ago
its great to finally see an aussie biotech actually generate some revenue,in terms of market potential i assume
the market doesnt apportion any value to other markets through bayer. (let alone valuing the company at only $15m.)if the net profit attributable to scigen is $us 270m what on earth is the gross value of the contract.this must rank as a very strong buy.